Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity

Abstract Background Lysophosphatidic acid (LPA) plays important roles in a variety of biological responses, especially in the area of vascular biology, and the determination of its plasma concentration is believed to be important. Several mechanisms are known to be involved in the metabolism of LPA. Methods To identify factors that may determine the plasma concentrations of this important bioactive lipid, we examined its concentrations using an enzymatic cycling assay and related parameters in 146 healthy subjects. Results The LPA concentration was significantly higher in women (mean ± SD, 0.103 ± 0.032 μmol/L; n = 47) than in men (0.077 ± 0.026 μmol/L; n = 99). A multiple regression analysis showed a strong positive correlation between the plasma LPA concentration and serum lysophospholipase D (lysoPLD) activity, while the LPA concentration was correlated with the plasma lysophosphatidylcholine (LPC) concentration only in men. Other lipid-related parameters were only slightly correlated or were not correlated with the LPA concentration. Conclusions Our findings suggested that conversion from LPC by lysoPLD might be the major route for LPA production in plasma.

[1]  H. Ikeda,et al.  Suppression of lysophosphatidic acid and lysophosphatidylcholine formation in the plasma in vitro: proposal of a plasma sample preparation method for laboratory testing of these lipids. , 2007, Analytical biochemistry.

[2]  Kazuhiro Nakamura,et al.  Both Plasma Lysophosphatidic Acid and Serum Autotaxin Levels are Increased in Chronic Hepatitis C , 2007, Journal of clinical gastroenterology.

[3]  H. Arai,et al.  Measurement of lysophospholipase D/autotaxin activity in human serum samples. , 2007, Clinical biochemistry.

[4]  Y. Kishi,et al.  Autotaxin Stabilizes Blood Vessels and Is Required for Embryonic Vasculature by Producing Lysophosphatidic Acid* , 2006, Journal of Biological Chemistry.

[5]  H. Ikeda,et al.  Platelet release of beta-thromboglobulin and platelet factor 4 and serotonin in plasma samples. , 2005, Clinical biochemistry.

[6]  S. Pyne,et al.  Lipid phosphate phosphatases and lipid phosphate signalling. , 2005, Biochemical Society transactions.

[7]  J. Chun.  Lysophospholipids in the nervous system. , 2005, Prostaglandins & other lipid mediators.

[8]  J. Chun,et al.  Cell surface receptors in lysophospholipid signaling. , 2004, Seminars in cell & developmental biology.

[9]  W. Siess,et al.  Thrombogenic and atherogenic activities of lysophosphatidic acid , 2004, Journal of cellular biochemistry.

[10]  A. Tokumura.  Metabolic pathways and physiological and pathological significances of lysolipid phosphate mediators , 2004, Journal of cellular biochemistry.

[11]  D. Baker,et al.  Subtype-Selective Antagonists of Lysophosphatidic Acid Receptors Inhibit Platelet Activation Triggered by the Lipid Core of Atherosclerotic Plaques , 2003, Circulation.

[12]  G. Mills,et al.  The emerging role of lysophosphatidic acid in cancer , 2003, Nature Reviews Cancer.

[13]  S. Imamura,et al.  A novel colorimetric assay for the determination of lysophosphatidic acid in plasma using an enzymatic cycling method. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[14]  R. Taguchi,et al.  Serum Lysophosphatidic Acid Is Produced through Diverse Phospholipase Pathways* , 2002, The Journal of Biological Chemistry.

[15]  K. Fukuzawa,et al.  Identification of Human Plasma Lysophospholipase D, a Lysophosphatidic Acid-producing Enzyme, as Autotaxin, a Multifunctional Phosphodiesterase* , 2002, The Journal of Biological Chemistry.

[16]  G. Mills,et al.  Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production , 2002, The Journal of cell biology.

[17]  Toru Suzuki,et al.  Diagnostic implications of circulating oxidized low density lipoprotein levels as a biochemical risk marker of coronary artery disease. , 2002, Clinical biochemistry.

[18]  Y. Soda,et al.  An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma. , 2002, Clinical biochemistry.

[19]  D. Baker,et al.  Multiple Mechanisms Linked to Platelet Activation Result in Lysophosphatidic Acid and Sphingosine 1-Phosphate Generation in Blood* , 2002, The Journal of Biological Chemistry.

[20]  M. Macey,et al.  Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system. , 2002, Clinical chemistry.

[21]  A. Morris,et al.  Roles for lipid phosphate phosphatases in regulation of cellular signaling. , 2002, Biochimica et biophysica acta.

[22]  T. Ohmori,et al.  Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells , 2000 .

[23]  M Markman,et al.  Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. , 1998, JAMA.

[24]  L. Liotta,et al.  cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterases. , 1994, The Journal of biological chemistry.

[25]  I. Fahrenfort,et al.  The bioactive phospholipid lysophosphatidic acid is released from activated platelets. , 1993, The Biochemical journal.

[26]  Akanuma Yasuo,et al.  A new colorimetric method for the determination of plasma lecithin-cholesterol acyltransferase activity , 1977 .